In vivo porcine lipopolysaccharide inflammation models to study immunomodulation of drugs

Veterinary Immunology and Immunopathology

Volumn 166, Issue 3-4, 2015, Pages 58-69

  Wyns, H ^a   Plessers, E ^a   De Backer, P ^a   Meyer, E ^a   Croubels, S ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

(N)SAIDs; Acute phase response; Antimicrobial drugs; Immunomodulation; LPS; Pigs

Indexed keywords

ACUTE PHASE PROTEIN; ANTIINFECTIVE AGENT; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; DEXAMETHASONE; ENDOTOXIN; HAPTOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; STEROID; THROMBOXANE A2; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA; BACTERIAL POLYSACCHARIDE; IMMUNOLOGIC FACTOR; LIPOPOLYSACCHARIDE;

ACUTE PHASE RESPONSE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; CYTOKINE RELEASE; ENZYME INHIBITION; FEVER; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PIG; PULMONARY HYPERTENSION; REVIEW; SEPTIC SHOCK; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; IMMUNOLOGY; PATHOPHYSIOLOGY; SWINE DISEASE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MURINAE; NEGIBACTERIA; SUIDAE; SUS;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNOLOGIC FACTORS; INFLAMMATION; LIPOPOLYSACCHARIDES; POLYSACCHARIDES, BACTERIAL; SWINE; SWINE DISEASES;

EID: 84938745607     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2015.06.001     Document Type: Review

References (128)

1. Adams H.R. Prostaglandins, related factors, and cytokines. Veterinary Pharmacology and Therapeutics 2001, Ames, Iowa, USA. 8th edition.
2. Alava M.A., González-Ramón N., Heegaard P., Guzylack S., Toussaint M.J.M., Lipperheide C., Madec F., Gruys E., Eckersall P.D., Lampreave F., Piñeiro A. Pig-MAP, porcine acute phase proteins and standardisation of assays in Europe. Comp. Haematol. Int. 1997, 7:208-213.
3. Algarra M., Gomes D., Esteves da Silva J.C. Current analytical strategies for C-reactive protein quantification in blood. Clin. Chim. Acta 2013, 415:1-9.
4. Araujo P., Mengesha Z., Lucena E., Grung B. Development and validation of an extraction method for the determination of pro-inflammatory eicosanoids in human plasma using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2013.
5. Bailly S., Fay M., Roche Y., Gougerot-Pocidalo M.A. Effects of quinolones on tumor necrosis factor production by human monocytes. Int. J. Immunopharmacol. 1990, 12:31-36.
6. Baumann H., Gauldie J. The acute phase response. Immunol. Today 1994, 15:74-80.
7. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009, 30:475-487.
8. Blatteis C.M., Li S., Li Z., Feleder C., Perlik V. Cytokines, PGE2 and endotoxic fever: a re-assessment. Prostaglandins Other Lipid Mediat. 2005, 76:1-18.
9. Blecha F. Immunomodulation: a means of disease prevention in stressed livestock. J. Anim. Sci. 1988, 66:2084-2090.
10. Brown J., Wang H., Hajishengallis G.N., Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J. Dent. Res. 2011, 90:417-427.
11. Buras J.A., Holzmann B., Sitkovsky M. Animal models of sepsis: setting the stage. Nat. Rev. Drug Discov. 2005, 4:854-865.
12. Cagiola M., Severi G., Menichelli M., Forti K., Petrucci P., Agostino M., Pasquali P. In vitro down regulation of pro-inflammatory cytokines induced by LPS tolerance in pig CD14+ cells. Vet. Immunol. Immunopathol. 2006, 112:316-320.
13. Carroll J.A., Arthington J.D., Chase C.C. Early weaning alters the acute-phase reaction to an endotoxin challenge in beef calves. J. Anim. Sc. 2009, 87:4167-4172.
14. Carroll J.A., Carter D.B., Korte S.W., Prather R.S. Evaluation of the acute phase response in cloned pigs following a lipopolysaccharide challenge. Domest. Anim. Endocrinol. 2005, 29:564-572.
15. Cao X.Y., Dong M., Shen J.Z., Wu B.B., Wu C.M., Du X.D., Wang Z., Qi Y.T., Li B.Y. Tilmicosin and tylosin have anti-inflammatory properties via modulation of COX-2 and iNOS gene expression and production of cytokines in LPS-induced macrophages and monocytes. Int. J. Antimicrob. Agents 2006, 27:431-438.
16. Cavaillon J.M., Adib-Conquy M. Monocytes/macrophages and sepsis. Crit. Care Med. 2005, 33(12 Suppl.):S506-S509.
17. Čulić O., Eraković V., Parnham M.J. Anti-inflammatory effects of macrolide antibiotics. Eur. J. Pharmacol. 2001, 429:209-229.
18. Curry S.L., Cogar S.M., Cook J.L. Nonsteroidal antiinflammatory drugs: a review. J. Am. Anim. Hosp. Assoc. 2005, 41:298-309.
19. Dänicke S., Brosig B., Kersten S., Kluess J., Kahlert S., Panther P., Diesing A.-K., Rothkötter H.-J. The Fusarium toxin deoxynivalenol (DON) modulates the LPS induced acute phase reaction in pigs. Toxicol. Lett. 2013, 220:172-180.
20. De Boever S., Neirinckx E.A., Meyer E., de Baere S., Beyaert R., de Backer P., Croubels S. Pharmacodynamics of tepoxalin, sodium-salicylate and ketoprofen in an intravenous lipopolysaccharide inflammation model in broiler chickens. J. Vet. Pharmacol. Ther. 2010, 33:564-572.
21. Dickneite G., Leithäuser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscl. Throm. Vasc. 1999, 19:1566-1572.
22. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997, 112:321S-329S.
23. Drieghe S.A., Alsaadi H., Tugirimana P.L., Delanghe J.R. A new high-sensitive nephelometric method for assaying serum C-reactive protein based on phosphocholine interaction. Clin. Chem. Lab. Med. 2014, 52:861-867.
24. Ebdrup L., Krog J., Granfeldt A., Larsen P.O., Vestergaard C., Hokland M., Tonnesen E. Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation. APMIS 2008, 116:352-360.
25. Eckersall P.D., Saini P.K., McComb C. The acute phase response of acid soluble glycoprotein, alpha(1)-acid glycoprotein, ceruloplasmin, haptoglobin and C-reactive protein, in the pig. Vet. Immunol. Immunopathol. 1996, 51:377-385.
26. EMA, European Medicines Agency Guideline for the conduct of efficacy studies for non-steroidal anti-inflammatory drugs. EMEA/CVMP/237/01-FINAL 2001, (latest accessed: 9.2.14).
27. Escribano D., Campos P.H., Gutierrez A.M., Le Floc'h N., Ceron J.J., Merlot E. Effect of repeated administration of lipopolysaccharide on inflammatory and stress markers in saliva of growing pigs. Vet. J. 2014, 200(3):393-397.
28. Fairbrother J.M., Nadeau E., Gyles C.L. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim. Health Res. Rev. 2005, 6:17-39.
29. Fairnbairn L., Kapetanovic R., Sester D.P., Hume D.A. The mononuclear phagocyte system of the pig as a model for understanding human innate immunity and disease. J. Leukoc. Biol. 2011, 89:855-871.
30. Fairnbairn L., Kapetanovic R., Beraldi D., Sester D.P., Tuggle C.K., Archibald A.L., Hume D.A. Comparative analysis of monocyte subsets in the pig. J. Immunol. 2013, 190:6389-6396.
31. Ferguson D.C., Dirikolu L., Hoenig M. Glucocorticoids, mineralocorticoids, and adrenolytic drugs. Veterinary Pharmacology and Therapeutics 2009, 771-802. Wiley-Blackwell, Iowa, USA. Ninth (Ed.).
32. Fingola F.F., Albertino S.R., Abrantes, Sde M., Zamith H.P. Intralaboratory validation of kinetic chromogenic Limulus amebocyte lysate assay for bacterial endotoxin determination in anti-bothropic serum. J. Pharm. Biomed. Anal. 2013, 85:93-98.
33. Fink M.P., Heard S.O. Laboratory models of sepsis and septic shock. J. Surg. Res. 1990, 49:186-196.
34. Frank J.W., Carroll J.A., Allee G.L., Zannelli M.E. The effects of thermal environment and spray-dried plasma on the acute-phase response of pigs challenged with lipopolysaccharide. J. Anim. Sci. 2003, 81:1166-1176.
35. Frank J.W., Mellencamp M.A., Carroll J.A., Boyd R.D., Allee G.L. Acute feed intake and acute-phase protein responses following a lipopolysaccharide challenge in pigs from two dam lines. Vet. Immunol. Immunopathol. 2005, 107:179-187.
36. Friton G.M., Schmidt H., Schrodl W. Clinical and anti-inflammatory effects of treating endotoxin-challenged pigs with meloxicam. Vet. Rec. 2006, 159:552-557.
37. Gasthuys F., Baert K., De Backer P. Repetitive intravenous catheterisation for pharmacokinetic studies in pigs. Vlaams Diergen. Tijds. 1999, 68:85-90.
38. Gerros T.C., Semrad S.D., Proctor R.A., LaBorde A. Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. Am. J. Vet. Res. 1993, 54:2121-2127.
39. Ghezzi P., Melillo G., Meazza C., Sacco S., Pellegrini L., Asti C., Porzio S., Marullo A., Sabbatini V., Caselli G., Bertini R. Differential contribution of R and S isomers in ketoprofen anti-inflammatory activity: role of cytokine modulation. J. Pharmacol. Exp. Ther. 1998, 287:969-974.
40. González-Ramón N., Alava M.A., Sarsa J.A., Piñeiro M., Escartin A., Garcia-Gil A., Lampreave F., Piñeiro A. The major acute phase protein in pigs is homologous to human plasma kallikrein sensitive PK-120. FEBS Lett. 1995, 11:227-230.
41. Goscinski G., Lipcsey M., Eriksson M., Larsson A., Tano E., Sjolin J. Endotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shock. Crit. Care 2004, 8:R35-R41.
42. Heegaard P.M.H., Klausen J., Nielsen J.P., González-Ramón N., Piñeiro M., Lampreave F., Alava M.A. The porcine acute phase response to infection with Actinobacillus pleuropneumoniae. Haptoglobin, c-reactive protein, major acute phase protein and serum amyloid A protein sensitive indicators of infection. Comp. Biochem. Physiol. 1998, 119B:365-373.
43. Heegaard P.M.H., Stockmarr A., Pineiro M., Carpintero R., Lampreave F., Campbell F.M., Eckersall P.D., Toussaint M.J.M., Gruys E., Sorensen N.S. Optimal combinations of acute phase proteins for detecting infectious disease in pigs. Vet. Res. 2011, 42.
44. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 1990, 265:621-636.
45. Heumann D., Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin. Chim. Acta 2002, 323:59-72.
46. Hersh E.V., Moore P.A., Ross G.L. Over-the-counter analgesics and antipyretics: a critical assessment. Clin. Therap. 2000, 22:500-548.
47. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J. Immunol. 2000, 165:618-622.
48. Holger J.S., Dries D.J., Barringer K.W., Peake B.J., Flottemesch T.J., Marini J.J. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad. Emerg. Med. 2010, 17:429-435.
49. Ianaro A., Ialenti A., Maffia P., Sautebin L., Rombola L., Carnuccio R., Iuvone T., D'Acquisto F., Di Rosa M. Anti-inflammatory activity of macrolide antibiotics. J. Pharmacol. Exp. Ther. 2000, 292:156-163.
50. Jerala R. Structural biology of the LPS recognition. Int. J. Med. Microbiol. 2007, 297:353-363.
51. Johannisson A., Jonasson R., Dernfalk J., Jensen-Waern M. Simultaneous detection of porcine proinflammatory cytokines using multiplex flow cytometry by the xMAP (TM) technology. Cytometry A 2006, 69A:391-395.
52. John E., Pais P., Furtado N., Chin A., Radhakrishnan J., Fornell L., Lumpaopong A., Beier U.H. Early effects of lipopolysaccharide on cytokine release, hemodynamic and renal function in newborn piglets. Neonatology 2008, 93:106-112.
53. Johnson R.W., von Borell E. Lipopolysaccharide-induced sickness behavior in pigs is inhibited by pretreatment with indomethacin. J. Anim. Sci. 1994, 72:309-314.
54. Kanitz E., Tuchscherer M., Tuchscherer A., Stabenow B., Manteuffel G. Neuroendocrine and immune responses to acute endotoxemia in suckling and weaned piglets. Biol. Neonate 2002, 81:203-209.
55. Kanoh S., Rubin B.K. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin. Microbiol. Rev. 2010, 23:590-615.
56. Klosterhalfen B., Horstmann-Jungemann K., Vogel P., Flohe S., Offner F., Kirkpatrick C.J., Heinrich P.C. Time course of various inflammatory mediators during recurrent endotoxemia. Biochem. Pharmacol. 1992, 43:2103-2109.
57. Lampreave F., Gonzalezramon N., Martinezayensa S., Hernandez M.A., Lorenzo H.K., Garciagil A., Pineiro A. Characterization of the acute-phase serum protein response in pigs. Electrophoresis 1994, 15:672-676.
58. Lawson S., Lunney J., Zuckermann F., Osorio F., Nelson E., Welbon C., Clement T., Fang Y., Wong S., Kulas K., Christopher-Hennings J. Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination. Vaccine 2010, 28:5356-5364.
59. Leininger M.T., Portocarrero C.P., Schinckel A.P., Spurlock M.E., Bidwell C.A., Nielsen J.N., Houseknecht K.L. Physiological response to acute endotoxemia in swine: effect of genotype on energy metabolites and leptin. Domest. Anim. Endocrinol. 2000, 18:71-82.
60. Leiva M., Ruiz-Bravo A., Jimenez-Valera M. Effects of telithromycin in in vitro and in vivo models of lipopolysaccharide-induced airway inflammation. Chest 2008, 134:20-29.
61. Levenbrown Y., Penfil S., Rodriguez E., Zhu Y., Hossain J., Bhat A.M., Hesek A., O'Neil K.B., Tobin K., Shaffer T.H. Use of insulin to decrease septic shock-induced myocardial depression in a porcine model. Inflammation 2013, 36:1494-1502.
62. Llamas Moya S., Boyle L., Lynch P.B., Arkins S. Pro-inflammatory cytokine and acute phase protein responses to low-dose lipopolysaccharide (LPS) challenge in pigs. Anim. Sci. 2006, 82:527-534.
63. Lorne E., Dupont H., Abraham E. Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine?. Intensive Care Med. 2010, 36:1826-1835.
64. Mair K.H., Sedlak C., Käser T., Pasternak A., Levast B., Gerner W., Saalmüller A., Summerfield A., Gerdts V., Wilson H.L., Meurens F. The porcine innate immune system: an update. Dev. Comp. Immunol. 2014, 45:321-343.
65. Martich G.D., Boujoukos A.J., Suffredini A.F. Response of man to endotoxin. Immunobiology 1993, 187:403-416.
66. Meurens F., Summerfield A., Nauwynck H., Saif L., Gerdts V. The pig: a model for human infectious diseases. Trends Microbiol. 2012, 20:50-57.
67. Miyake K. Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbiol. 2004, 12:186-192.
68. Monshouwer M., Witkamp R.F., Nijmeijer S.M., Van Leengoed L.A.M.G., Vernooy H.C.M., Verheijden J.H.M., Van Miert A.S.J.P.A.M. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. J. Vet. Pharmacol. Ther. 1996, 19:382-388.
69. Morikawa K., Watabe H., Araake M., Morikawa S. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob. Agents Chemother. 1996, 40:1366-1370.
70. Müller G., Steinbach G., Berndt A., Köhler H. Effects of various applications of lipopolysaccharides on blood parameters of pigs. J. Vet. Med. B 2002, 49:429-437.
71. Murtaugh M.P., Baarsch M.J., Zhou Y., Scamurra R.W., Lin G. Inflammatory cytokines in animal health and disease. Vet. Immunol. Immunopathol. 1996, 54:45-55.
72. Mustonen K., Banting A., Raekallio M., Heinonen M., Peltoniemi O.A., Vainio O. Dose-response investigation of oral ketoprofen in pigs challenged with Escherichia coli endotoxin. Vet. Rec. 2012, 171:70.
73. Myers M.J., Farrell D.E., Baker J.D., Cope C.V., Evock-Clover C.M., Steele N.C. Challenge differentially affects cytokine production and metabolic status of growing and finishing swine. Domest. Anim. Endocrinol. 1999, 17:345-360.
74. Myers M.J., Farrell D.E., Palmer D.C., Post L.O. Inflammatory mediator production in swine following endotoxin challenge with or without co-administration of dexamethasone. Int. Immunopharmacol. 2003, 3:571-579.
75. Nakajima Y., Momotani E., Takahashi H., Ishikawa Y., Ito T., Kanesaki M., Madarame H. Endogenous tumor necrosis factor (TNF) production and modification of pathological lesions in experimental Escherichia coli endotoxemia of piglets. Vet. Immunol. Immunopathol. 1995, 45:45-54.
76. Netea M.G., Kullberg B.J., Van der Meer J.W.M. Circulating cytokines as mediators of fever. Clin. Infect. Dis. 2000, 31:S178-S184.
77. Nielsen J.S., Larsson A., Rix T., Nyboe R., Gjedsted J., Krog J., Ledet T., Tønnesen E. The effect of activated protein C on plasma cytokine levels in a porcine model of acute endotoxemia. Intensive Care Med. 2007, 33:1085-1093.
78. Olson N.C., Brown T.T., Anderson D.L. Dexamethasone and indomethacin modify endotoxin-induced respiratory failure in pigs. J. Appl. Physiol. 1985, 58:274-284.
79. Olson N.C., Hellyer P.W., Dodam J.R. Mediators and vascular effects in response to endotoxin. Br. Vet. J. 1995, 151:489-522.
80. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
81. Pålsson-McDermott E.M., O'Neill L.A. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004, 113:153-162.
82. Parnham M.J. Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections. Curr. Opin. Infect. Dis. 2005, 18:125-131.
83. Parrott R.F., Vellucci S.V., Goode J.A., Lloyd D.M., Forsling M.L. Interrelated adrenocortical and neurohypophysial responses associated with fever in endotoxin-treated pigs. Am. J. Physiol. 1997, 273:R1046-R1052.
84. Peri F., Piazza M., Calabrese V., Damore G., Cighetti R. Exploring the LPS/TLR4 signal pathway with small molecules. Biochem. Soc. Trans. 2010, 38:1390-1395.
85. Peters S.M., Yancy H., Deaver C., Jones Y.L., Kenyon E., Chiesa O.A., Esparza J., Screven R., Lancaster V., Stubbs J.T., Yang M., Wiesenfeld P.L., Myers M.J. In vivo characterization of inflammatory biomarkers in swine and the impact of flunixin meglumine administration. Vet. Immunol. Immunopathol. 2012, 148:236-242.
86. Petersen H.H., Nielsen J.P., Heegaard P.M. Application of acute phase protein measurements in veterinary clinical chemistry. Vet. Res. 2004, 35:163-187.
87. Pettipher E.R., Wimberly D.J. Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shock. Cytokine 1994, 6:500-503.
88. Philippart F., Cavaillon J.M. Sepsis mediators. Curr. Infect. Dis. Rep. 2007, 9:358-365.
89. Pineiro M., Pineiro C., Carpintero R., Morales J., Campbell F.M., Eckersall P.D., Toussaint M.J.M., Lampreave F. Characterisation of the pig acute phase protein response to road transport. Vet. J. 2007, 173:669-674.
90. Plessers E., Wyns H., Watteyn A., Pardon B., De Backer P., Croubels S. Characterization of an intravenous lipopolysaccharide inflammation model in calves with respect to the acute phase response. Vet. Immunol. Immunopathol. 2015, 163:46-56.
91. Poli-de-Figueiredo L.F., Garrido A.G., Nakagawa N., Sannomiya P. Experimental models of sepsis and their clinical relevance. Shock 2008, 30(Suppl. 1):53-59.
92. Purswani M.U., Eckert S.J., Arora H.K., Noel G.J. Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model. J. Antimicrob. Chemother. 2002, 50:51-58.
93. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zahringer U., Seydel U., Di Padova F., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994, 8:217-225.
94. Rietschel E.T., Kirikae T., Schade F.U., Ulmer A.J., Holst O., Brade H., Schmidt G., Mamat U., Grimmecke H.D., Kusumoto S., et al. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 1993, 187:169-190.
95. Rose M., Menge M., Bohland C., Zschiesche E., Wilhelm C., Kilp S., Metz W., Allan M., Ropke R., Nurnberger M. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae. J. Vet. Pharmacol. Ther. 2013, 36:140-153.
96. Rutledge H.R., Jiang W., Yang J., Warg L.A., Schwartz D.A., Pisetsky D.S., Yang I.V. Gene expression profiles of RAW264.7 macrophages stimulated with preparations of LPS differing in isolation and purity. Innate Immun. 2012, 18:80-88.
97. Ruud T.E., Gundersen Y., Wang J.E., Foster S.J., Thiemermann C., Aasen A.O. Activation of cytokine synthesis by systemic infusions of lipopolysaccharide and peptidoglycan in a porcine model in vivo and in vitro. Surg. Infect. 2007, 8:495-503.
98. Salichs M., Sabate D., Ciervo O., Homedes J. Comparison of the antipyretic efficacy of ketoprofen, acetylsalicylic acid, and paracetamol, orally administered to swine. J. Vet. Pharmacol. Ther. 2012, 35:198-201.
99. Schmidhammer R., Wassermann E., Germann P., Redl H., Ullrich R. Infusion of increasing doses of endotoxin induces progressive acute lung injury but prevents early pulmonary hypertension in pigs. Shock 2006, 25:389-394.
100. Schrauwen E.M., Houvenaghel A.M. Endotoxin shock in the pig: beneficial effects of pretreatment with prednisolone sodium succinate. Am. J. Vet. Res. 1984, 45:1650-1653.
101. Schrauwen E.M., Houvenaghel A.M. Endotoxic shock in the awake young pig: absence of beneficial effect of prednisolone sodium succinate treatment. Am. J. Vet. Res. 1985, 46:1770-1774.
102. Schrauwen E., Cox E., Houvenaghel A. Escherichia coli sepsis and endotoxemia in conscious young pigs. Vet. Res. Commun. 1988, 12:295-303.
103. Schrauwen E., Thoonen H., Hoorens J., Houvenaghel A. Pathophysiological effects of endotoxin infusion in young pigs. Br. Vet. J. 1986, 142:364-370.
104. Schrauwen E., Vandeplassche G., Laekeman G., Houvenaghel A. Endotoxic shock in the piglet: beneficial effects of prostaglandin synthesis inhibition. Prostaglandins Leukot. Med. 1984, 13:271-278.
105. Seydel U., Hawkins L., Schromm A.B., Heine H., Scheel O., Koch M.H., Brandenburg K. The generalized endotoxic principle. Eur. J. Immunol. 2003, 33:1586-1592.
106. Slagman A.C., Bock C., Abdel-Aty H., Vogt B., Gebauer F., Janelt G., Wohlgemuth F., Morgenstern R., Yapici G., Puppe A., Modersohn D., Mans D., Jerichow T., Ott S., Kunze R., Schrodl W., Janko C., Hermann M., Kalden J.R., Kern P., Parsch H., Kirschfink M., Schulz-Menger J., Rottgen R., Unger J.K., Frei U., Schindler R., Mockel M., Sheriff A. Specific removal of C-reactive protein by apheresis in a porcine cardiac infarction model. Blood Purif. 2011, 31:9-17.
107. Sorensen N.S., Tegtmeier C., Andresen L.O., Pineiro M., Toussaint M.J., Campbell F.M., Lampreave F., Heegaard P.M. The porcine acute phase protein response to acute clinical and subclinical experimental infection with Streptococcus suis. Vet. Immunol. Immunopathol. 2006, 113:157-168.
108. Sugiyama K., Shirai R., Mukae H., Ishimoto H., Nagata T., Sakamoto N., Ishii H., Nakayama S., Yanagihara K., Mizuta Y., Kohno S. Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin. Exp. Immunol. 2007, 147:540-546.
109. Swinkels J.M., Pijpers A., Vernooy J.C., Van Nes A., Verheijden J.H. Effects of ketoprofen and flunixin in pigs experimentally infected with Actinobacillus pleuropneumoniae. J. Vet. Pharmacol. Ther. 1994, 17:299-303.
110. Tauber S.C., Nau R. Immunomodulatory properties of antibiotics. Curr. Mol. Pharmacol. 2008, 1:68-79.
111. Teeling J.L., Cunningham C., Newman T.A., Perry V.H. The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: implications for a role of COX-1. Brain Behav. Immun. 2010, 24:409-419.
112. Tegeder I., Pfeilschifter J., Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 2001, 15:2057-2072.
113. Tirsoaga A., Novikov A., Adib-Conquy M., Werts C., Fitting C., Cavaillon J.-M., Caroff M. Simple method for repurification of endotoxins for biological use. Appl. Environ. Microbiol. 2007, 73:1803-1808.
114. Tobias P.S., Tapping R.I., Gegner J.A. Endotoxin interactions with lipopolysaccharide-responsive cells. Clin. Infect. Dis. 1999, 28:476-481.
115. Triantafilou M., Triantafilou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002, 23:301-304.
116. Tuchscherer M., Kanitz E., Puppe B., Tuchscherer A. Altered immunomodulation by glucocorticoids in neonatal pigs exposed to a psychosocial stressor. Pediatr. res. 2010, 68:473-478.
117. Tuchscherer M., Kanitz E., Puppe B., Tuchscherer A., Stabenow B. Effects of postnatal social isolation on hormonal and immune responses of pigs to an acute endotoxin challenge. Physiol. Behav. 2004, 82:503-511.
118. Tugirimana P.L., De Clercq D., Holderbeke A.L., Kint J.A., De Cooman L., Deprez P., Delanghe J.R. A functional turbidimetric method to determine C-reactive protein in horses. J. Vet. Diagn. Invest. 2011, 23:308-311.
119. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol. 1971, 231:232-235.
120. Verstrepen L., Bekaert T., Chau T.L., Tavernier J., Chariot A., Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell. Mol. Life Sci. 2008, 65:2964-2978.
121. Warren E.J., Finck B.N., Arkins S., Kelley K.W., Scamurra R.W., Murtaugh M.P., Johnson R.W. Coincidental changes in behavior and plasma cortisol in unrestrained pigs after intracerebroventricular injection of tumor necrosis factor-alpha. Endocrinology 1997, 138:2365-2371.
122. Webel D.M., Finck B.N., Baker D.H., Johnson R.W. Time course of increased plasma cytokines, cortisol, and urea nitrogen in pigs following intraperitoneal injection of lipopolysaccharide. J. Anim. Sci. 1997, 75:1514-1520.
123. Williams P.N., Collier C.T., Carroll J.A., Welsh T.H., Laurenz J.C. Temporal pattern and effect of sex on lipopolysaccharide-induced stress hormone and cytokine response in pigs. Domest. Anim. Endocrinol. 2009, 37:139-147.
124. Winkler G.C., Cheville N.F. Monocytic origin and postnatal mitosis of intravascular macrophages in the porcine lung. J. Leukoc. Biol. 1985, 38:471-480.
125. Wright K.J., Balaji R., Hill C.M., Dritz S.S., Knoppel E.L., Minton J.E. Integrated adrenal, somatotropic, and immune responses of growing pigs to treatment with lipopolysaccharide. J. Anim. Sci. 2000, 78:1892-1899.
126. Wyns H., Croubels S., Demeyere K., Watteyn A., De Backer P., Meyer E. Development of a cytometric bead array screening tool for the simultaneous detection of pro-inflammatory cytokines in porcine plasma. Vet. Immunol. Immunopathol. 2013, 151:28-36.
127. Wyns, H., Meyer, E., Plessers, E., Watteyn, A., van Bergen, T., Schauvliege, S., De Baere, S., Devreese, M., De Backer, P., Croubels, S., 2015. Modulation of gamithromycin and ketoprofen on in vitro and in vivo porcine lipopolysaccharide-induced inflammation (conditionally accepted).
128. Zhang X., Song Y., Ci X., An N., Fan J., Cui J., Deng X. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. Int. Immunopharmacol. 2008, 8:982-988.